Remi Samain

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.

CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells.

Journal: Science advances
Published: October 18, 2023

Preclinical to clinical utility of ROCK inhibitors in cancer.

Preclinical to clinical utility of ROCK inhibitors in cancer.

Journal: Trends in cancer
Published: October 04, 2022

AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration.

AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration.

Journal: Nature communications
Published: May 13, 2022

Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.

Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.

Journal: The Journal of pathology
Published: April 18, 2022

Rho GTPase signaling in cancer progression and dissemination.

Rho GTPase signaling in cancer progression and dissemination.

Journal: Physiological reviews
Published: September 20, 2021

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages.

Journal: Cellular and molecular gastroenterology and hepatology
Published: June 30, 2020

Cancer-associated fibroblasts: activin A adds another string to their bow.

Cancer-associated fibroblasts: activin A adds another string to their bow.

Journal: EMBO molecular medicine
Published: March 28, 2020

FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer.

FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer.

Journal: EMBO molecular medicine
Published: January 14, 2020

Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer.

Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer.

Journal: Gut
Published: September 11, 2018

eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.

eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer.

Journal: JCI insight
Published: April 29, 2018

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.

Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.

Journal: Oncotarget
Published: July 16, 2015

Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.

Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance.

Journal: EMBO molecular medicine
Published: April 03, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026